Table 7.
95% Confidence Interval | ||||
---|---|---|---|---|
Hazard Ratio | Lower | Upper | p-value | |
Age (years, median) | 1.04 | 1.01 | 1.07 | 0.005 |
Sex (female) | 0.99 | 0.67 | 1.45 | 0.95 |
Year of diagnosis, median (inter-quartile range) | 0.99 | 0.92 | 1.06 | 0.69 |
CDCC Score (reference: 0) | ||||
1 | 0.78 | 0.51 | 1.20 | 0.26 |
2+ | 1.10 | 0.64 | 1.92 | 0.73 |
Facility type (reference: non-academic) | ||||
Academic/research program | 0.71 | 0.44 | 1.14 | 0.15 |
Insurance type (reference: private) | ||||
Government | 1.15 | 0.71 | 1.86 | 0.57 |
No insurance | 0.95 | 0.33 | 2.71 | 0.92 |
Tumor grade (reference: well differentiated) | ||||
Poorly differentiated | 2.09 | 0.27 | 16.4 | 0.48 |
Undifferentiated | 2.75 | 0.35 | 21.7 | 0.34 |
Adjuvant therapy (reference: none) | ||||
Chemotherapy | 0.58 | 0.40 | 0.84 | 0.004 |